October 30, 2014
A Delaware federal judge invalidated part of a DNA technology patent Genetic Technologies Ltd. accused Bristol-Myers Squibb Co. and a Sanofi-Aventis SA unit of infringing because it merely described a natural law, dooming the claim under the U.S. Supreme Court's landmark Mayo v. Prometheus decision.
May 02, 2012
A patent held by Genetic Technologies Ltd. on a method of using DNA in genetic analysis should be invalidated in light of the U.S. Supreme Court's recent Prometheus ruling, Sanofi-Aventis SA's animal health unit Merial Ltd. said in a re-examination request filed Monday.